Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GRTP1 antisense RNA 1 (GRTP1-AS1) is a long non-coding RNA (lncRNA) gene located in the human genome that does not encode a protein[3][6][7]. It is classified as an antisense RNA because its transcript is oriented opposite to that of a protein-coding gene, potentially allowing for regulatory interactions with sense transcripts. Like other lncRNAs, GRTP1-AS1 is suggested to participate in regulation of gene expression and is implicated in cellular processes such as cell proliferation and apoptosis, though its specific molecular functions and disease relevance remain largely uncharacterized in the scientific literature to date[6][9]. It is listed by major gene databases (NCBI Gene, HGNC, GeneCards) as a non-coding RNA, and is not recognized as a primary therapeutic target, receptor, enzyme, transporter, or transcription factor[3][5][7]. No drug interactions, validated biomarkers, or notable safety concerns are described for this gene, reflecting its current status as a gene of uncertain or emerging functional significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GRTP1 antisense RNA 1 (GRTP1-AS1).